Reflections on implementation of HBV, HCV, and HIV nucleic acid testing in blood screening;Reflexions concernant le depistage des acides nucleiques des virus des hepatites B et C et du virus de l'immunodeficience humaine dans la qualification biologique des dons

Transfusion Clinique et Biologique

Volumn 5, Issue 2, 1998, Pages 139-146

  Andre Botte C ^a   Barlet, V ^a   Barin, F ^a   Boudart, D ^a   Chamaret, S ^a   Courouce A M ^a   Durand, F ^a   Elghouzzi, M H ^a   Escher, J ^a   Lemaire, J M ^a   Lunel, F ^a   Maniez, M ^a   Mattlinger, B ^a,b   Menault, M ^a   Moncharmont, P ^a   Morel, P ^a   Morin, F ^a   Mouillot, L ^a   Noel L ^a   North, M L ^a   Pillonel, J ^a   Piquet, Y ^a   Rouzioux, C ^a,b   Saura, C ^a   Smilovici, W ^a   Trepo, C ^a,c   Coste, J ^a   Defer, C ^a   Loiseau, P ^a   Zoulim, F ^a,c   more..

^a INSTITUT NATIONAL DE LA TRANSFUSION SANGUINE   (France)

^b Institut Necker   (France)

^c INSERM   (France)

Author keywords

Blood donation screening; HBV; HCV; HIV; Nucleic acid testing; Pools; Window period

Indexed keywords

NUCLEIC ACID; HEPATITIS ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; VIRUS DNA; VIRUS RNA;

ARTICLE; BLOOD DONOR; BLOOD SAMPLING; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; NUCLEIC ACID ANALYSIS; VIRUS CHARACTERIZATION; VIRUS INFECTION; AUTOMATION; BIOSYNTHESIS; BLOOD; BLOOD BANK; BLOOD TRANSFUSION; COMPARATIVE STUDY; EQUIPMENT; GENETIC VARIABILITY; GENETICS; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INSTRUMENTATION; ISOLATION AND PURIFICATION; MASS SCREENING; METHODOLOGY; ORGANIZATION AND MANAGEMENT; POLYMERASE CHAIN REACTION; PREDICTION AND FORECASTING; REVIEW; SENSITIVITY AND SPECIFICITY; SERODIAGNOSIS; SEROLOGY; STANDARD; TIME; VIREMIA; VIROLOGY;

AIDS SERODIAGNOSIS; AUTOMATION; BLOOD BANKS; BLOOD DONORS; BLOOD TRANSFUSION; DNA, VIRAL; EQUIPMENT CONTAMINATION; HEPACIVIRUS; HEPATITIS ANTIBODIES; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HIV; HIV ANTIBODIES; HIV INFECTIONS; HUMANS; MASS SCREENING; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE OF TESTS; RNA, VIRAL; SENSITIVITY AND SPECIFICITY; SEROLOGIC TESTS; TIME FACTORS; VARIATION (GENETICS); VIREMIA;

EID: 0345471885     PISSN: 12467820     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1246-7820(98)80004-9     Document Type: Article

References (13)

1. 1 Schreiber GB, Busch MP, Kleiman SH, Korelitz JJ for the NHLBI Retrovirus Epidemiology Blood Donor Study. Current risk of transfusion-transmitted viral infections and impact of new donor screening tests. N Engl J Med 1996 ; 334 : 1685-90
2. 2 Couroucé AM, Pillonel J et les groupes de travail de la SFTS. Risque de transmission d'infection virale par transfusion de dérivés sanguins labiles. Med Ther 1997 ; 3 : 858-62
3. 3 Rehermann B, Ferrari C, Pasquinelli C, Chisari FV. The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response. Nat Med 1996 ; 2 : 1104-8
4. 4 Hugues W, Barr A, Dow BC, Follet EAC, Barbara JAJ. A multicentre assessment of the specificity of ten anti-HBc screening tests. Transfus Med 1995 ; 5 : 225-30
5. 5 Busch M, Satten GA. Time course of viremia and antibody seroconversion following human immunodeficiency virus exposure. Am J Med 1997 ; 102 : 117-24
6. 6 Prowse C, Ludlam CA, Yap PL. Human Parvovirus B19 and blood products. Vox Sang 1997 ; 72 : 1-10
7. 7 Yee TT, Lee CA, Pasi KJ. Life-threatening human Parvovirus B19 infection in immunocompetent haemophilia. Lancet 1995 ; 345 : 794-5
8. 8 Zucker-Franklin D, Gorman JG. HLTV-I provirus in seronegative healthy blood donors. Lancet 1997 ; 349 : 999
9. 9 Loussert-Ajaka I, Ly TD, Chaix ML, Ingrand D, Saragosti S, Couroucé AM et al. HIV-1/HIV-2 seronegativity in HIV-1 subtype O infected patients. Lancet 1994 ; 343 : 1393-4
10. 10 Coste J, Montes B, Reynes J, Peeters M, Segarra C, Delaporte E, Segondy M. Effect of HIV-1 RNA quantification in plasma: comparative evaluation of three commercial assays. J Acquir Immune Defic Syndr Hum Retrovirol 1997 ; 15 : 174
11. 11 Dunne AL, Crowe SM. Comparison of branched DNA and reverse transcriptase polymerase chain reaction for quantifying six different HIV-1 subtypes in plasma. AIDS 1997 ; 11 : 126-7
12. 12 Hawkins A, Davidson F, Simmons P. Comparison of plasma virus loads among individuals infected with hepatitis C virus (VHC) genotypes 1, 2 and 3 by quantiplex VHC RNA assay versions 1 and 2, Roche Monitor assay, and in house limiting dilution method. J Clin Microbiol 1997 ; 35 : 187-92
13. 13 Barin F, Couroucé AM, Pillonel J, Buzelay L and the Retrovirus Study Group of the French Society of Blood Transfusion. Increasing diversity of HIV-1 M serotypes in French blood donors over a 10-year period (1985-95). AIDS 1997 ; 11 :1503-8